US Patent Issued to CHARITE-UNIVERSITAETSMEDIZIN BERLIN on Feb. 24 for "Ratio between PLGF and sFLt1 is predictive for neural invasion in patients suffering from pancreatic cancer" (German Inventor)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,560,611, issued on Feb. 24, was assigned to CHARITE-UNIVERSITAETSMEDIZIN BERLIN (Berlin).

"Ratio between PLGF and sFLt1 is predictive for neural invasion in patients suffering from pancreatic cancer" was invented by Christian Fischer (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to a method for identifying neural invasion in a pancreatic cancer patient, the method comprising the steps of: determining in a sample of a pancreatic cancer patient the expression level of PlGF and sFlt1; and calculating a ratio of the expression levels of PlGF and sFlt1, wherein the expression level of PlGF forms part either of the n...